Effective human defense against E. histolytica: High amoebicidal activity of lymphocytes and monocytes in amoebic liver abscess patients until 3 months follow-up

Parasitology International

Volumn 52, Issue 3, 2003, Pages 193-202

  Vohra, Harpreet ^a   Kaur, Upninder ^a   Sharma, Anil K ^a   Bhalla, Veena ^a   Bhasin, Deepak ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Adherence; CMI response; Cytotoxicity; E. histolytica

Indexed keywords

CD3 ANTIGEN;

ADULT; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL ADHESION; CELL KILLING; CELL STIMULATION; CELL VIABILITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENTAMOEBA HISTOLYTICA; FEMALE; FOLLOW UP; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFECTION RESISTANCE; LIVER AMEBIASIS; MACROPHAGE; MALE; MONOCYTE; PARASITE IMMUNITY; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TIME; TROPHOZOITE;

ENTAMOEBA; ENTAMOEBA HISTOLYTICA;

EID: 0141560683     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5769(03)00025-4     Document Type: Article

References (10)

1. Walsh J.A. Problems in recognition and diagnosis of amoebiasis: estimation of the global magnitude of morbidity and mortability. Rev Infect Dis. 8:1996;228-238.
2. Ravdin J.I. Immunobiology of human infection. Pathol Immunopathol Res. 8:1989;179-205.
3. Salata R.A., Pearson R.D., Ravdin J.I. Interaction of human leukocytes and Entamoeba histolytica. J Clin Invest. 76:1985;491-499.
4. Salata R.A., Martinez-Palomo A., Murray H.W., et al. Patients treated for amebic liver abscess develop cell mediated immune responses effective in vitro against Entamoeba histolytica. J Immunol. 136:1996;2633-2639.
5. Flores-Romo L., Bacon K.B., Estrada-Gracia T., Shibayama M., Tsutumi V., Martinez-Palomo A. A fluorescence-based quantitative adhesion assay to study interaction between Entamoeba histolytica and human enterocytes. Effect of preinflammatory cytokines. J Immunol Methods. 166:1993;243-250.
6. Stanley S.L. Jr. Protective immunity to amebiasis: new insights and new challenges. J Inf Dis. 184:2001;504-506.
7. Salata R.A., Ravdin J.I. Immunoprophylaxis. Ravdin J.I. Amebiasis: human infection by Entamoeba histolytica. 1988;793-801 Wiley, New York.
8. Ravdin J.I., Guerrant R.L. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest. 68:1981;1305-1313.
9. Vines R.R., Ramakrishanan G., Rogers J.B., Lockhart L.A., Mann B.J., Petri W.A. Jr. Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains a β2 integrin motif. Mol Biol Cell. 9:1998;2069-2079.
10. Adler P., Wond S., Lee Y.C., Petri W.A. Jr., Schnaar R.L. High affinity binding of the Entamoeba histolytica lectin to polyvalent N-acetyl galactosaminides. J Biol Chem. 270:1995;5164-5171.